The goal is to give patients what they want-less hassle-while also giving them what they need: consistent dosing. McHugh’s lab is in the drug delivery business. “And I don’t blame them at all-that’s terrible.” “People hate getting injections into their eyes,” McHugh says. But even though it’s effective, dosing adherence is notoriously low. And sometimes we’re missing out on a lot.”įor example, the injectable drug bevacizumab can be used to treat macular degeneration, a leading cause of blindness. “Are we really squeezing all the utility out of those drugs and vaccines?” asks Kevin McHugh, a bioengineer at Rice University. Plus, the Covid pandemic illustrated the difficulties of delivering perishable follow-up vaccine shots to regions with no cold chain. And essential medicines, like insulin, can be brutally expensive. It’s that some drugs, like HIV medications, require unwavering commitment. The issue isn’t that people are unwilling to take their prescriptions. If drugs aren’t taken regularly, on time, and in the right doses, the treatment may not work, and the person’s condition can worsen. On average, patients with chronic illnesses follow their prescribed treatments about 50 percent of the time.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |